CYH
Bearish signalScored 2026-08-27 Drivers: fundamentals. Moteurs : fondamentaux.
Research, not advice.
À propos
Community Health Systems, Inc.
- Nom
- Community Health Systems, Inc.
- Secteur
- Healthcare
- Industrie
- Medical - Care Facilities
- Bourse
- NYSE
- Capitalisation
- $405.4M
- Employés
- 50,500
- PDG
- Kevin J. Hammons
- Site web
- https://www.chs.net
- Marché
- AUNAAVNSCMPSEHABFDMTINNV
Community Health Systems, Inc. (CYH) operates as a major healthcare provider across the United States, focusing on the ownership, leasing, and management of general acute care hospitals. The organization offers a comprehensive array of medical services, including emergency care, general and specialized surgical procedures, critical care, internal medicine, obstetrics, and various diagnostic capabilities. Additionally, they provide psychiatric services, rehabilitation programs, skilled nursing, and in-home care. Beyond its hospital-based offerings, the company delivers outpatient services through a diverse network of facilities. These encompass primary care practices, urgent care centers, independent emergency departments, ambulatory surgery centers, advanced imaging and diagnostic centers, retail health clinics, and direct-to-consumer virtual health consultations. As of December 31, 2021, CYH's holdings included 83 hospitals, either owned or leased. This total comprised 81 general acute care facilities and two specialized stand-alone rehabilitation or psychiatric hospitals, collectively providing a capacity of 13,289 licensed patient beds. The company was established in 1985 and its corporate headquarters are situated in Franklin, Tennessee.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 40 000 titres (~118 400,00 $ US)
- Insiders
- JENNINGS WILLIAM NORRIS
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$118,400
Avg sell (VWAP, 90d window) $2.96 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-25
- Last synced
-
2026-08-31 10:14:36
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-25 | JENNINGS WILLIAM NORRIS | Sell · S | 40,000 | $2.96 | $118,400 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Bearish signalScored 2026-08-27 Drivers: fundamentals. Moteurs : fondamentaux.
CYH presents a deeply distressed financial profile with negative equity, debt-to-EBITDA exceeding 5x, and a negative interest coverage ratio, leaving virtually no margin of safety.
The first sentence of the analysis written for CYH on 2026-08-27 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Pulls against a bullish reading. Current ratio 1.46 · operating margin -79%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 8.7% | 41.7% | 40.7% | 40.2% | 41.1% | |
| Ebit Margin | 12.8% | 6.7% | 7.0% | 5.9% | 10.3% | |
| Ebitda Margin | 16.2% | 9.9% | 10.4% | 9.6% | 13.8% | |
| Operating Profit Margin | -79.4% | 4.3% | 7.7% | 6.7% | 11.3% | |
| Pretax Profit Margin | 5.8% | -2.2% | 1.7% | 2.9% | 4.0% | |
| Continuous Operations Profit Margin | 5.4% | -2.9% | 0.1% | 1.5% | 3.0% | |
| Net Profit Margin | 4.1% | -4.1% | -1.1% | 0.4% | 1.9% | |
| Bottom Line Profit Margin | 4.1% | -4.1% | -1.1% | 0.4% | 1.9% | |
| Current Ratio | 1.465 | 1.408 | 1.498 | 1.410 | 1.472 | |
| Quick Ratio | 1.319 | 1.267 | 1.345 | 1.248 | 1.321 | |
| Solvency Ratio | 0.067 | -0.007 | 0.019 | 0.032 | 0.041 | |
| Cash Ratio | 0.118 | 0.016 | 0.018 | 0.054 | 0.214 | |
| Price To Earnings Ratio | 0.821 | -0.767 | -3.069 | 12.000 | 7.313 | |
| Price To Earnings Growth Ratio | -0.004 | -0.003 | 0.008 | -0.150 | -0.124 | |
| Forward Price To Earnings Growth Ratio | -0.004 | -0.003 | 0.008 | -0.150 | -0.124 | |
| Price To Earnings Diluted Ratio | 0.828 | -0.767 | -3.069 | 12.343 | 7.562 | |
| Price To Earnings Diluted Growth Ratio | -0.004 | -0.003 | 0.008 | -0.154 | -0.126 | |
| Price To Book Ratio | -0.300 | -0.206 | -0.293 | -0.407 | -1.230 | |
| Price To Sales Ratio | 0.033 | 0.031 | 0.033 | 0.046 | 0.136 | |
| Price To Free Cash Flow Ratio | 2.010 | 3.292 | -1.588 | -4.839 | -2.812 | |
| Price To Operating Cash Flow Ratio | 0.770 | 0.823 | 1.943 | 1.855 | -12.879 | |
| Debt To Assets Ratio | 0.877 | 0.861 | 0.842 | 0.845 | 0.843 | |
| Debt To Equity Ratio | -8.307 | -6.323 | -8.746 | -9.062 | -9.345 | |
| Debt To Capital Ratio | 1.137 | 1.188 | 1.129 | 1.124 | 1.120 | |
| Long Term Debt To Capital Ratio | 1.150 | 1.205 | 1.141 | 1.136 | 1.133 | |
| Financial Leverage Ratio | -9.472 | -7.343 | -10.384 | -10.731 | -11.091 | |
| Working Capital Turnover Ratio | 12.598 | 12.497 | 12.732 | 12.144 | 8.803 | |
| Operating Cash Flow Ratio | 0.246 | 0.205 | 0.098 | 0.137 | -0.055 | |
| Operating Cash Flow Sales Ratio | 0.043 | 0.038 | 0.017 | 0.025 | -0.011 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.383 | 0.250 | -1.224 | -0.383 | 4.580 | |
| Debt Service Coverage Ratio | 1.980 | 1.172 | 1.130 | 0.972 | 1.485 | |
| Interest Coverage Ratio | -11.397 | 0.628 | 1.150 | 0.957 | 1.584 | |
| Short Term Operating Cash Flow Coverage Ratio | 4.310 | 3.556 | 1.448 | 1.775 | -0.736 | |
| Operating Cash Flow Coverage Ratio | 0.047 | 0.040 | 0.017 | 0.024 | -0.010 | |
| Capital Expenditure Coverage Ratio | 1.621 | 1.333 | 0.450 | 0.723 | -0.279 | |
| Dividend Paid And Capex Coverage Ratio | 1.621 | 1.333 | 0.450 | 0.723 | -0.279 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 5.811 | 9.976 | 9.687 | 10.982 | 8.188 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 8.7% | ▼-33.1% | ▼-25.8% |
| Ebit Margin | 12.8% | ▲6.1% | ▲4.2% |
| Ebitda Margin | 16.2% | ▲6.3% | ▲4.2% |
| Operating Profit Margin | -79.4% | ▼-83.7% | ▼-69.5% |
| Pretax Profit Margin | 5.8% | ▲8.0% | ▲3.4% |
| Continuous Operations Profit Margin | 5.4% | ▲8.3% | ▲4.0% |
| Net Profit Margin | 4.1% | ▲8.2% | ▲3.8% |
| Bottom Line Profit Margin | 4.1% | ▲8.2% | ▲3.8% |
| Current Ratio | 1.465 | ▲0.057 | ▲0.014 |
| Quick Ratio | 1.319 | ▲0.052 | ▲0.019 |
| Solvency Ratio | 0.067 | ▲0.074 | ▲0.036 |
| Cash Ratio | 0.118 | ▲0.102 | ▲0.034 |
| Price To Earnings Ratio | 0.821 | ▲1.588 | ▼-2.439 |
| Price To Earnings Growth Ratio | -0.004 | ▼-0.001 | ▲0.050 |
| Forward Price To Earnings Growth Ratio | -0.004 | ▼-0.001 | ▲0.050 |
| Price To Earnings Diluted Ratio | 0.828 | ▲1.594 | ▼-2.552 |
| Price To Earnings Diluted Growth Ratio | -0.004 | ▼-0.002 | ▲0.052 |
| Price To Book Ratio | -0.300 | ▼-0.093 | ▲0.187 |
| Price To Sales Ratio | 0.034 | ▲0.002 | ▼-0.022 |
| Price To Free Cash Flow Ratio | 2.010 | ▼-1.282 | ▲2.797 |
| Price To Operating Cash Flow Ratio | 0.770 | ▼-0.053 | ▲2.268 |
| Debt To Assets Ratio | 0.877 | ▲0.016 | ▲0.024 |
| Debt To Equity Ratio | -8.307 | ▼-1.984 | ▲0.050 |
| Debt To Capital Ratio | 1.137 | ▼-0.051 | ▼-0.003 |
| Long Term Debt To Capital Ratio | 1.149 | ▼-0.056 | ▼-0.003 |
| Financial Leverage Ratio | -9.472 | ▼-2.129 | ▲0.332 |
| Working Capital Turnover Ratio | 12.598 | ▲0.102 | ▲0.844 |
| Operating Cash Flow Ratio | 0.246 | ▲0.041 | ▲0.120 |
| Operating Cash Flow Sales Ratio | 0.043 | ▲0.005 | ▲0.021 |
| Free Cash Flow Operating Cash Flow Ratio | 0.383 | ▲0.133 | ▼-0.338 |
| Debt Service Coverage Ratio | 1.980 | ▲0.808 | ▲0.632 |
| Interest Coverage Ratio | -11.397 | ▼-12.025 | ▼-9.981 |
| Short Term Operating Cash Flow Coverage Ratio | 4.309 | ▲0.754 | ▲2.239 |
| Operating Cash Flow Coverage Ratio | 0.047 | ▲0.007 | ▲0.023 |
| Capital Expenditure Coverage Ratio | 1.621 | ▲0.288 | ▲0.851 |
| Dividend Paid And Capex Coverage Ratio | 1.621 | ▲0.288 | ▲0.851 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 5.811 | ▼-4.165 | ▼-3.118 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $418.1M | $395.0M | $408.1M | $556.5M | $1.69B | |
| Enterprise value | $11.74B | $12.46B | $12.54B | $12.83B | $14.00B | |
| EV / Sales | 0.94x | 0.99x | 1.00x | 1.05x | 1.13x | |
| EV / Op. cash flow | 21.62x | 25.96x | 59.73x | 42.76x | -106.89x | |
| EV / Free cash flow | 56.43x | 103.83x | -48.81x | -111.53x | -23.34x | |
| EV / EBITDA | 5.81x | 9.98x | 9.69x | 10.98x | 8.19x | |
| Net debt / EBITDA | 5.60x | 9.66x | 9.37x | 10.51x | 7.20x | |
| Current ratio | 1.47x | 1.41x | 1.50x | 1.41x | 1.47x | |
| Income quality | 0.80x | -0.93x | -1.58x | 6.52x | -0.57x | |
| Graham net-net | -$89 | -$101 | -$102 | -$105 | -$108 | |
| Tax burden | 70.3% | 182.3% | -64.3% | 13.2% | 46.1% | |
| Interest burden | 45.4% | -33.6% | 23.8% | 48.5% | 39.0% | |
| Working capital | $1.03B | $956.0M | $1.07B | $896.0M | $1.11B | |
| Invested capital | $9.61B | $10.32B | $11.10B | $11.39B | $11.82B | |
| Return on assets | 3.9% | -3.7% | -0.9% | 0.3% | 1.5% | |
| Operating ROA | -72.7% | 3.8% | 6.6% | 5.5% | 9.0% | |
| Return on tangible assets | 5.2% | -5.1% | -1.3% | 0.4% | 2.1% | |
| Return on equity | -36.5% | 27.0% | 9.6% | -3.4% | -16.8% | |
| Return on invested capital | -83.2% | 4.6% | 0.6% | 3.3% | 7.9% | |
| Return on capital employed | -90.2% | 4.6% | 7.8% | 6.6% | 10.9% | |
| Earnings yield | 121.7% | -130.6% | -32.6% | 8.3% | 13.6% | |
| Free cash flow yield | 49.8% | 30.4% | -63.0% | -20.7% | -35.6% | |
| Capex / Op. cash flow | 61.7% | 75.0% | 222.4% | 138.3% | -358.0% | |
| Capex / Depreciation | 78.6% | 74.1% | 92.5% | 77.7% | 86.9% | |
| Capex / Sales | 2.7% | 2.8% | 3.7% | 3.4% | 3.8% | |
| SG&A / Sales | 0.0% | 2.4% | 2.6% | 2.6% | 2.5% | |
| R&D / Sales | 0.0% | 0.0% | 0.6% | 0.7% | 0.9% | |
| Stock comp / Sales | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Intangibles / Total assets | 26.2% | 28.2% | 28.8% | 29.9% | 29.5% | |
| Days sales outstanding | 66d | 71d | 69d | 64d | 64d | |
| Days payables outstanding | 27d | 39d | 40d | 34d | 36d | |
| Operating cycle | 76d | 87d | 85d | 82d | 82d | |
| Cash conversion cycle | 49d | 48d | 45d | 47d | 46d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-21 Community Health Systems (CYH) Up 7.2% Since Last Earnings Report: Can It Continue? Community Health Systems (CYH) reported earnings 30 days ago. What''s next for the stock?
- 2026-08-17 Community Health Trades at a Deep Discount to Peers: Hold or Fold? CYH trades at a deep discount to peers as acquisitions, cost control and debt reduction progress, but cash flow remains a concern.
- 2026-07-23 Community Health Systems, Inc. (CYH) Q2 2026 Earnings Call Transcript Community Health Systems, Inc. (CYH) Q2 2026 Earnings Call Transcript
- 2026-07-23 Community Health Systems Q2 Earnings Call Highlights Community Health Systems NYSE: CYH reported second-quarter 2026 results below its internal expectations and reduced its full-year outlook, citing higher uninsured volumes, weaker elective surgical demand among commercially insured patients and unfavorable payer and service mix trends.
- 2026-07-23 Community Health Q2 Loss Wider Than Expected, 2026 View Lowered CYH posts a wider-than-expected Q2 loss as revenues fall and the company cuts its 2026 revenue, EBITDA and earnings outlook.
- 2026-07-22 Community Health Systems (CYH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Community Health Systems (CYH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 2026-07-22 Community Health Systems (CYH) Reports Q2 Loss, Lags Revenue Estimates Community Health Systems (CYH) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.05 per share a year ago.
- 2026-07-22 Community Health Systems, Inc. Announces Second Quarter Ended June 30, 2026 Results FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) (the “Company”) today announced financial and operating results for the three and six months ended June 30, 2026. The following highlights the financial and operating results for the three months ended June 30, 2026. Net operating revenues totaled $2.825 billion. Net income attributable to Community Health Systems, Inc. stockholders was $70 million, or $0.51 per share (diluted), compared to $282 million, or $2.09 per s.
- 2026-07-20 Sell Alert: 3 REITs Facing Likely Dividend Cuts Most REIT dividends remain safe, but not all. High yields can hide serious balance sheet risks. Three REITs may cut dividends soon.
- 2026-07-16 Can Higher Occupancy Offset Lower Admissions in CYH''s Q2 Earnings? Community Health heads into Q2 earnings with mixed operating trends as stronger occupancy meets lower admissions and a smaller hospital portfolio.